Detalhe da pesquisa
1.
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.
Cell
; 154(5): 1074-1084, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23993097
2.
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
J Transl Med
; 21(1): 714, 2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821919
3.
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.
Lancet Oncol
; 17(10): 1435-1444, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575027
4.
Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.
Proc Natl Acad Sci U S A
; 108(33): 13728-33, 2011 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21795608
5.
Matriptase-2/NR4A3 axis switches TGF-ß action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Oncogene
; 41(20): 2833-2845, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418692
6.
Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor.
PLoS One
; 17(7): e0270803, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776912
7.
A birth-to-death view of mRNA from the RNA recognition motif perspective.
Biochem Mol Biol Educ
; 36(1): 1-8, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21591152
8.
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
Elife
; 62017 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28191869
9.
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Oncotarget
; 5(15): 6425-36, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115390
10.
Prostate cancer-from steroid transformations to clinical translation.
Nat Rev Urol
; 9(12): 721-4, 2012 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23027067
11.
A three-lead, programmable, and microcontroller-based electrocardiogram generator with frequency domain characteristics of heart rate variability.
Rev Sci Instrum
; 83(4): 045109, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559578
12.
Abiraterone inhibits 3ß-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
Clin Cancer Res
; 18(13): 3571-9, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753664